Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-11

Clinical Trial Update: Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating amiloride for slowing the progression of chronic kidney disease, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiloride (amiloride)

Snippet

Sponsor: Odense University Hospital | Conditions: Chronic Kidney Disease(CKD), Proteinuria | Phase 2 | Status: RECRUITING